Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuma Murakami

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
FEBS Letters|December 27, 2011
Geranyl modification on the tryptophan residue of ComXRO-E-2 pheromone by a cell-free systemFumitada Tsuji, Ayako Ishihara, Keiko Kurata, et al.
The Journal of Experimental Biology|June 21, 2014
Altered regulation of sleep and feeding contributes to starvation resistance in Drosophila melanogasterPavel Masek, Lauren A Reynolds, Wesley L Bollinger, et al.
International Journal of Alzheimer'S Disease|January 15, 2011
E22Δ Mutation in Amyloid β-Protein Promotes β-Sheet Transformation, Radical Production, and Synaptotoxicity, But Not NeurotoxicityTakayuki Suzuki, Kazuma Murakami, Naotaka Izuo, et al.
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23]Kazuhiro Irie, Kazuma Murakami, Yuichi Masuda, et al.
ACS Chemical Neuroscience|July 11, 2012
Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23Kazuma Murakami, Yuko Horikoshi-Sakuraba, Nakaba Murata, et al.
Chemical Communications (Cambridge, England)|June 1, 2018
Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomersKazuma Murakami, Takuya Yoshioka, Shiori Horii, et al.
Environmental Research|May 3, 2026
Do epigenetic aging biomarkers mediate the association between exposure and health outcomes? A scoping review of mediation analysisRyosuke Fujii, Yoshiki Tsuboi, Andres Cardenas, et al.
ACS Chemical Neuroscience|December 28, 2016
Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant NeurotoxicityYumi Irie, Kazuma Murakami, Mizuho Hanaki, et al.
Journal of Epidemiology|October 5, 2025
Jcvrisk: An R Package for Population-Level Estimation of Cardiovascular Risk Scores in Japanese AdultsHiroshi Okumiyama, Ryosuke Fujii, Yoshiki Tsuboi, et al.
Neurobiology of Disease|January 14, 2020
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease modelTomohiro Imamura, Yuki T Yanagihara, Yasumasa Ohyagi, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
FEBS Letters|December 27, 2011
Geranyl modification on the tryptophan residue of ComXRO-E-2 pheromone by a cell-free systemFumitada Tsuji, Ayako Ishihara, Keiko Kurata, et al.
The Journal of Experimental Biology|June 21, 2014
Altered regulation of sleep and feeding contributes to starvation resistance in Drosophila melanogasterPavel Masek, Lauren A Reynolds, Wesley L Bollinger, et al.
International Journal of Alzheimer'S Disease|January 15, 2011
E22Δ Mutation in Amyloid β-Protein Promotes β-Sheet Transformation, Radical Production, and Synaptotoxicity, But Not NeurotoxicityTakayuki Suzuki, Kazuma Murakami, Naotaka Izuo, et al.
Rinsho Shinkeigaku = Clinical Neurology|January 27, 2012
[Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23]Kazuhiro Irie, Kazuma Murakami, Yuichi Masuda, et al.
ACS Chemical Neuroscience|July 11, 2012
Monoclonal antibody against the turn of the 42-residue amyloid β-protein at positions 22 and 23Kazuma Murakami, Yuko Horikoshi-Sakuraba, Nakaba Murata, et al.
Chemical Communications (Cambridge, England)|June 1, 2018
Role of the carboxy groups of triterpenoids in their inhibition of the nucleation of amyloid β42 required for forming toxic oligomersKazuma Murakami, Takuya Yoshioka, Shiori Horii, et al.
Environmental Research|May 3, 2026
Do epigenetic aging biomarkers mediate the association between exposure and health outcomes? A scoping review of mediation analysisRyosuke Fujii, Yoshiki Tsuboi, Andres Cardenas, et al.
ACS Chemical Neuroscience|December 28, 2016
Synthetic Models of Quasi-Stable Amyloid β40 Oligomers with Significant NeurotoxicityYumi Irie, Kazuma Murakami, Mizuho Hanaki, et al.
Journal of Epidemiology|October 5, 2025
Jcvrisk: An R Package for Population-Level Estimation of Cardiovascular Risk Scores in Japanese AdultsHiroshi Okumiyama, Ryosuke Fujii, Yoshiki Tsuboi, et al.
Neurobiology of Disease|January 14, 2020
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease modelTomohiro Imamura, Yuki T Yanagihara, Yasumasa Ohyagi, et al.
Pageof 9